Recent Advances in the Development of Membrane-derived Vesicles for Cancer Immunotherapy

Mao, J.J.; Pillai, G.G.; Andrade, C.J.; Ligibel, J.A.; Basu, P.; Cohen, L.; Khan, I.A.; Mustian, K.M.; Puthiyedath, R.; Dhiman, K.S.; Lao, L.; Ghelman, R.; Cáceres Guido, P.; Lopez, G.; Gallego-Perez, D.F.; Salicrup, L.A. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J. Clin., 2022, 72(2), 144-164.
[http://dx.doi.org/10.3322/caac.21706] [PMID: 34751943]

Hassan, F.; El-Hiti, G.A.; Abd-Allateef, M.; Yousif, E. Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells. Saudi Med. J., 2017, 38(4), 359-365.
[http://dx.doi.org/10.15537/smj.2017.4.17061] [PMID: 28397941]

Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell, 2011, 144(5), 646-674.
[http://dx.doi.org/10.1016/j.cell.2011.02.013] [PMID: 21376230]

Marabelle, A.; Tselikas, L.; de Baere, T.; Houot, R. Intratumoral immunotherapy: Using the tumor as the remedy. Ann. Oncol., 2017, 28(Suppl. 12), xii33-xii43.
[http://dx.doi.org/10.1093/annonc/mdx683] [PMID: 29253115]

Izci, M.; Maksoudian, C.; Manshian, B.B.; Soenen, S.J. The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem. Rev., 2021, 121(3), 1746-1803.
[http://dx.doi.org/10.1021/acs.chemrev.0c00779] [PMID: 33445874]

Zhu, R.; Zhang, F.; Peng, Y.; Xie, T.; Wang, Y.; Lan, Y. Current progress in cancer treatment using nanomaterials. Front. Oncol., 2022, 12, 930125.
[http://dx.doi.org/10.3389/fonc.2022.930125] [PMID: 35912195]

Shao, H.; Im, H.; Castro, C.M.; Breakefield, X.; Weissleder, R.; Lee, H. New technologies for analysis of extracellular vesicles. Chem. Rev., 2018, 118(4), 1917-1950.
[http://dx.doi.org/10.1021/acs.chemrev.7b00534] [PMID: 29384376]

Whiteside, T.L. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem. Soc. Trans., 2013, 41(1), 245-251.
[http://dx.doi.org/10.1042/BST20120265] [PMID: 23356291]

Verdi, J.; Ketabchi, N.; Noorbakhsh, N.; Saleh, M.; Ebrahimi-Barough, S.; Seyhoun, I.; Kavianpour, M. Development and clinical application of tumor-derived exosomes in patients with cancer. Curr. Stem Cell Res. Ther., 2022, 17(1), 91-102.
[http://dx.doi.org/10.2174/1574888X16666210622123942] [PMID: 34161212]

Lai, R.C.; Yeo, R.W.Y.; Tan, K.H.; Lim, S.K. Exosomes for drug delivery — a novel application for the mesenchymal stem cell. Biotechnol. Adv., 2013, 31(5), 543-551.
[http://dx.doi.org/10.1016/j.biotechadv.2012.08.008] [PMID: 22959595]

Hiemstra, T.F.; Charles, P.D.; Gracia, T.; Hester, S.S.; Gatto, L.; Al-Lamki, R.; Floto, R.A.; Su, Y.; Skepper, J.N.; Lilley, K.S.; Karet Frankl, F.E. Human urinary exosomes as innate immune effectors. J. Am. Soc. Nephrol., 2014, 25(9), 2017-2027.
[http://dx.doi.org/10.1681/ASN.2013101066] [PMID: 24700864]

Rodriguez, B.V.; Kuehn, M.J. Staphylococcus aureus secretes immunomodulatory RNA and DNA via membrane vesicles. Sci. Rep., 2020, 10(1), 18293.
[http://dx.doi.org/10.1038/s41598-020-75108-3] [PMID: 33106559]

Fuhrmann, G.; Serio, A.; Mazo, M.; Nair, R.; Stevens, M.M. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J. Control. Release, 2015, 205, 35-44.
[http://dx.doi.org/10.1016/j.jconrel.2014.11.029] [PMID: 25483424]

Fuhrmann, G.; Herrmann, I.K.; Stevens, M.M. Cell-derived vesicles for drug therapy and diagnostics: Opportunities and challenges. Nano Today, 2015, 10(3), 397-409.
[http://dx.doi.org/10.1016/j.nantod.2015.04.004] [PMID: 28458718]

McAndrews, K.M.; Kalluri, R. Mechanisms associated with biogenesis of exosomes in cancer. Mol. Cancer, 2019, 18(1), 52.
[http://dx.doi.org/10.1186/s12943-019-0963-9] [PMID: 30925917]

Lo Cicero, A.; Stahl, P.D.; Raposo, G. Extracellular vesicles shuffling intercellular messages: For good or for bad. Curr. Opin. Cell Biol., 2015, 35, 69-77.
[http://dx.doi.org/10.1016/j.ceb.2015.04.013] [PMID: 26001269]

de la Torre Gomez, C.; Goreham, R.V.; Bech Serra, J.J.; Nann, T.; Kussmann, M. “Exosomics”—A review of biophysics, biology and biochemistry of exosomes with a focus on human breast milk. Front. Genet., 2018, 9, 92.
[http://dx.doi.org/10.3389/fgene.2018.00092] [PMID: 29636770]

Ratajczak, M.Z.; Ratajczak, J. Extracellular microvesicles/exosomes: Discovery, disbelief, acceptance, and the future? Leukemia, 2020, 34(12), 3126-3135.
[http://dx.doi.org/10.1038/s41375-020-01041-z] [PMID: 32929129]

Théry, C.; Witwer, K.W.; Aikawa, E.; Alcaraz, M.J.; Anderson, J.D.; Andriantsitohaina, R.; Antoniou, A.; Arab, T.; Archer, F.; Atkin-Smith, G.K.; Ayre, D.C.; Bach, J.M.; Bachurski, D.; Baharvand, H.; Balaj, L.; Baldacchino, S.; Bauer, N.N.; Baxter, A.A.; Bebawy, M.; Beckham, C.; Bedina Zavec, A.; Benmoussa, A.; Berardi, A.C.; Bergese, P.; Bielska, E.; Blenkiron, C.; Bobis-Wozowicz, S.; Boilard, E.; Boireau, W.; Bongiovanni, A.; Borràs, F.E.; Bosch, S.; Boulanger, C.M.; Breakefield, X.; Breglio, A.M.; Brennan, M.Á.; Brigstock, D.R.; Brisson, A.; Broekman, M.L.D.; Bromberg, J.F.; Bryl-Górecka, P.; Buch, S.; Buck, A.H.; Burger, D.; Busatto, S.; Buschmann, D.; Bussolati, B.; Buzás, E.I.; Byrd, J.B.; Camussi, G.; Carter, D.R.F.; Caruso, S.; Chamley, L.W.; Chang, Y.T.; Chen, C.; Chen, S.; Cheng, L.; Chin, A.R.; Clayton, A.; Clerici, S.P.; Cocks, A.; Cocucci, E.; Coffey, R.J.; Cordeiro-da-Silva, A.; Couch, Y.; Coumans, F.A.W.; Coyle, B.; Crescitelli, R.; Criado, M.F.; D’Souza-Schorey, C.; Das, S.; Datta Chaudhuri, A.; de Candia, P.; De Santana, E.F.; De Wever, O.; del Portillo, H.A.; Demaret, T.; Deville, S.; Devitt, A.; Dhondt, B.; Di Vizio, D.; Dieterich, L.C.; Dolo, V.; Dominguez Rubio, A.P.; Dominici, M.; Dourado, M.R.; Driedonks, T.A.P.; Duarte, F.V.; Duncan, H.M.; Eichenberger, R.M.; Ekström, K.; Andaloussi, E.L. S.; Elie-Caille, C.; Erdbrügger, U.; Falcón-Pérez, J.M.; Fatima, F.; Fish, J.E.; Flores-Bellver, M.; Försönits, A.; Frelet-Barrand, A.; Fricke, F.; Fuhrmann, G.; Gabrielsson, S.; Gámez-Valero, A.; Gardiner, C.; Gärtner, K.; Gaudin, R.; Gho, Y.S.; Giebel, B.; Gilbert, C.; Gimona, M.; Giusti, I.; Goberdhan, D.C.I.; Görgens, A.; Gorski, S.M.; Greening, D.W.; Gross, J.C.; Gualerzi, A.; Gupta, G.N.; Gustafson, D.; Handberg, A.; Haraszti, R.A.; Harrison, P.; Hegyesi, H.; Hendrix, A.; Hill, A.F.; Hochberg, F.H.; Hoffmann, K.F.; Holder, B.; Holthofer, H.; Hosseinkhani, B.; Hu, G.; Huang, Y.; Huber, V.; Hunt, S.; Ibrahim, A.G.E.; Ikezu, T.; Inal, J.M.; Isin, M.; Ivanova, A.; Jackson, H.K.; Jacobsen, S.; Jay, S.M.; Jayachandran, M.; Jenster, G.; Jiang, L.; Johnson, S.M.; Jones, J.C.; Jong, A.; Jovanovic-Talisman, T.; Jung, S.; Kalluri, R.; Kano, S.; Kaur, S.; Kawamura, Y.; Keller, E.T.; Khamari, D.; Khomyakova, E.; Khvorova, A.; Kierulf, P.; Kim, K.P.; Kislinger, T.; Klingeborn, M.; Klinke, D.J., II; Kornek, M.; Kosanović M.M.; Kovács, Á.F.; Krämer-Albers, E.M.; Krasemann, S.; Krause, M.; Kurochkin, I.V.; Kusuma, G.D.; Kuypers, S.; Laitinen, S.; Langevin, S.M.; Languino, L.R.; Lannigan, J.; Lässer, C.; Laurent, L.C.; Lavieu, G.; Lázaro-Ibáñez, E.; Le Lay, S.; Lee, M.S.; Lee, Y.X.F.; Lemos, D.S.; Lenassi, M.; Leszczynska, A.; Li, I.T.S.; Liao, K.; Libregts, S.F.; Ligeti, E.; Lim, R.; Lim, S.K.; Linē A.; Linnemannstöns, K.; Llorente, A.; Lombard, C.A.; Lorenowicz, M.J.; Lörincz, Á.M.; Lötvall, J.; Lovett, J.; Lowry, M.C.; Loyer, X.; Lu, Q.; Lukomska, B.; Lunavat, T.R.; Maas, S.L.N.; Malhi, H.; Marcilla, A.; Mariani, J.; Mariscal, J.; Martens-Uzunova, E.S.; Martin-Jaular, L.; Martinez, M.C.; Martins, V.R.; Mathieu, M.; Mathivanan, S.; Maugeri, M.; McGinnis, L.K.; McVey, M.J.; Meckes, D.G., Jr; Meehan, K.L.; Mertens, I.; Minciacchi, V.R.; Möller, A.; Møller Jørgensen, M.; Morales-Kastresana, A.; Morhayim, J.; Mullier, F.; Muraca, M.; Musante, L.; Mussack, V.; Muth, D.C.; Myburgh, K.H.; Najrana, T.; Nawaz, M.; Nazarenko, I.; Nejsum, P.; Neri, C.; Neri, T.; Nieuwland, R.; Nimrichter, L.; Nolan, J.P.; Nolte-’t Hoen, E.N.M.; Noren Hooten, N.; O’Driscoll, L.; O’Grady, T.; O’Loghlen, A.; Ochiya, T.; Olivier, M.; Ortiz, A.; Ortiz, L.A.; Osteikoetxea, X.; Østergaard, O.; Ostrowski, M.; Park, J.; Pegtel, D.M.; Peinado, H.; Perut, F.; Pfaffl, M.W.; Phinney, D.G.; Pieters, B.C.H.; Pink, R.C.; Pisetsky, D.S.; Pogge von Strandmann, E.; Polakovicova, I.; Poon, I.K.H.; Powell, B.H.; Prada, I.; Pulliam, L.; Quesenberry, P.; Radeghieri, A.; Raffai, R.L.; Raimondo, S.; Rak, J.; Ramirez, M.I.; Raposo, G.; Rayyan, M.S.; Regev-Rudzki, N.; Ricklefs, F.L.; Robbins, P.D.; Roberts, D.D.; Rodrigues, S.C.; Rohde, E.; Rome, S.; Rouschop, K.M.A.; Rughetti, A.; Russell, A.E.; Saá, P.; Sahoo, S.; Salas-Huenuleo, E.; Sánchez, C.; Saugstad, J.A.; Saul, M.J.; Schiffelers, R.M.; Schneider, R.; Schøyen, T.H.; Scott, A.; Shahaj, E.; Sharma, S.; Shatnyeva, O.; Shekari, F.; Shelke, G.V.; Shetty, A.K.; Shiba, K.; Siljander, P.R.M.; Silva, A.M.; Skowronek, A.; Snyder, O.L., II; Soares, R.P.; Sódar, B.W.; Soekmadji, C.; Sotillo, J.; Stahl, P.D.; Stoorvogel, W.; Stott, S.L.; Strasser, E.F.; Swift, S.; Tahara, H.; Tewari, M.; Timms, K.; Tiwari, S.; Tixeira, R.; Tkach, M.; Toh, W.S.; Tomasini, R.; Torrecilhas, A.C.; Tosar, J.P.; Toxavidis, V.; Urbanelli, L.; Vader, P.; van Balkom, B.W.M.; van der Grein, S.G.; Van Deun, J.; van Herwijnen, M.J.C.; Van Keuren-Jensen, K.; van Niel, G.; van Royen, M.E.; van Wijnen, A.J.; Vasconcelos, M.H.; Vechetti, I.J., Jr; Veit, T.D.; Vella, L.J.; Velot, É.; Verweij, F.J.; Vestad, B.; Viñas, J.L.; Visnovitz, T.; Vukman, K.V.; Wahlgren, J.; Watson, D.C.; Wauben, M.H.M.; Weaver, A.; Webber, J.P.; Weber, V.; Wehman, A.M.; Weiss, D.J.; Welsh, J.A.; Wendt, S.; Wheelock, A.M.; Wiener, Z.; Witte, L.; Wolfram, J.; Xagorari, A.; Xander, P.; Xu, J.; Yan, X.; Yáñez-Mó, M.; Yin, H.; Yuana, Y.; Zappulli, V.; Zarubova, J.; Žėkas, V.; Zhang, J.; Zhao, Z.; Zheng, L.; Zheutlin, A.R.; Zickler, A.M.; Zimmermann, P.; Zivkovic, A.M.; Zocco, D.; Zuba-Surma, E.K. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles, 2018, 7(1), 1535750.
[http://dx.doi.org/10.1080/20013078.2018.1535750] [PMID: 30637094]

Alvarez-Erviti, L.; Seow, Y.; Yin, H.; Betts, C.; Lakhal, S.; Wood, M.J.A. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol., 2011, 29(4), 341-345.
[http://dx.doi.org/10.1038/nbt.1807] [PMID: 21423189]

Gao, J.; Wang, S.; Wang, Z. High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy. Biomaterials, 2017, 135, 62-73.
[http://dx.doi.org/10.1016/j.biomaterials.2017.05.003] [PMID: 28494264]

Watson, D.C.; Bayik, D.; Srivatsan, A.; Bergamaschi, C.; Valentin, A.; Niu, G.; Bear, J.; Monninger, M.; Sun, M.; Morales-Kastresana, A.; Jones, J.C.; Felber, B.K.; Chen, X.; Gursel, I.; Pavlakis, G.N. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials, 2016, 105, 195-205.
[http://dx.doi.org/10.1016/j.biomaterials.2016.07.003] [PMID: 27522254]

Jang, S.C.; Kim, O.Y.; Yoon, C.M.; Choi, D.S.; Roh, T.Y.; Park, J.; Nilsson, J.; Lötvall, J.; Kim, Y.K.; Gho, Y.S. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano, 2013, 7(9), 7698-7710.
[http://dx.doi.org/10.1021/nn402232g] [PMID: 24004438]

García-Manrique, P.; Gutiérrez, G.; Blanco-López, M.C. Fully artificial exosomes: Towards new theranostic biomaterials. Trends Biotechnol., 2018, 36(1), 10-14.
[http://dx.doi.org/10.1016/j.tibtech.2017.10.005] [PMID: 29074309]

Lu, M.; Zhao, X.; Xing, H.; Xun, Z.; Yang, T.; Cai, C.; Wang, D.; Ding, P. Liposome-chaperoned cell-free synthesis for the design of proteoliposomes: Implications for therapeutic delivery. Acta Biomater., 2018, 76, 1-20.
[http://dx.doi.org/10.1016/j.actbio.2018.03.043] [PMID: 29625253]

García-Manrique, P.; Matos, M.; Gutiérrez, G.; Pazos, C.; Blanco-López, M.C. Therapeutic biomaterials based on extracellular vesicles: Classification of bio-engineering and mimetic preparation routes. J. Extracell. Vesicles, 2018, 7(1), 1422676.
[http://dx.doi.org/10.1080/20013078.2017.1422676] [PMID: 29372017]

Jo, W.; Kim, J.; Yoon, J.; Jeong, D.; Cho, S.; Jeong, H.; Yoon, Y.J.; Kim, S.C.; Gho, Y.S.; Park, J. Large-scale generation of cell-derived nanovesicles. Nanoscale, 2014, 6(20), 12056-12064.
[http://dx.doi.org/10.1039/C4NR02391A] [PMID: 25189198]

Johnsen, K.B.; Gudbergsson, J.M.; Duroux, M.; Moos, T.; Andresen, T.L.; Simonsen, J.B. On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems – A commentary. J. Control. Release, 2018, 269, 10-14.
[http://dx.doi.org/10.1016/j.jconrel.2017.11.002] [PMID: 29126999]

Cheng, C.J.; Tietjen, G.T.; Saucier-Sawyer, J.K.; Saltzman, W.M. A holistic approach to targeting disease with polymeric nanoparticles. Nat. Rev. Drug Discov., 2015, 14(4), 239-247.
[http://dx.doi.org/10.1038/nrd4503] [PMID: 25598505]

Molinaro, R.; Corbo, C.; Martinez, J.O.; Taraballi, F.; Evangelopoulos, M.; Minardi, S.; Yazdi, I.K.; Zhao, P.; De Rosa, E.; Sherman, M.B.; De Vita, A.; Toledano Furman, N.E.; Wang, X.; Parodi, A.; Tasciotti, E. Biomimetic proteolipid vesicles for targeting inflamed tissues. Nat. Mater., 2016, 15(9), 1037-1046.
[http://dx.doi.org/10.1038/nmat4644] [PMID: 27213956]

Ramirez, M.I.; Amorim, M.G.; Gadelha, C.; Milic, I.; Welsh, J.A.; Freitas, V.M.; Nawaz, M.; Akbar, N.; Couch, Y.; Makin, L.; Cooke, F.; Vettore, A.L.; Batista, P.X.; Freezor, R.; Pezuk, J.A.; Rosa-Fernandes, L.; Carreira, A.C.O.; Devitt, A.; Jacobs, L.; Silva, I.T.; Coakley, G.; Nunes, D.N.; Carter, D.; Palmisano, G.; Dias-Neto, E. Technical challenges of working with extracellular vesicles. Nanoscale, 2018, 10(3), 881-906.
[http://dx.doi.org/10.1039/C7NR08360B] [PMID: 29265147]

Gardiner, C.; Vizio, D.D.; Sahoo, S.; Théry, C.; Witwer, K.W.; Wauben, M.; Hill, A.F. Techniques used for the isolation and characterization of extracellular vesicles: Results of a worldwide survey. J. Extracell. Vesicles, 2016, 5(1), 32945.
[http://dx.doi.org/10.3402/jev.v5.32945] [PMID: 27802845]

Li, P.; Kaslan, M.; Lee, S.H.; Yao, J.; Gao, Z. Progress in exosome isolation techniques. Theranostics, 2017, 7(3), 789-804.
[http://dx.doi.org/10.7150/thno.18133] [PMID: 28255367]

Zhao, Z.; Wijerathne, H.; Godwin, A.K.; Soper, S.A. Isolation and analysis methods of extracellular vesicles (EVs). Extracell. Vesicles Circ. Nucl. Acids, 2021, 2, 80-103.

Lamparski, H.G.; Metha-Damani, A.; Yao, J.Y.; Patel, S.; Hsu, D.H.; Ruegg, C.; Le Pecq, J.B. Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods, 2002, 270(2), 211-226.
[http://dx.doi.org/10.1016/S0022-1759(02)00330-7] [PMID: 12379326]

Li, X.; Corbett, A.L.; Taatizadeh, E.; Tasnim, N.; Little, J.P.; Garnis, C.; Daugaard, M.; Guns, E.; Hoorfar, M.; Li, I.T.S. Challenges and opportunities in exosome research—Perspectives from biology, engineering, and cancer therapy. APL Bioeng., 2019, 3(1), 011503.
[http://dx.doi.org/10.1063/1.5087122] [PMID: 31069333]

Tauro, B.J.; Greening, D.W.; Mathias, R.A.; Ji, H.; Mathivanan, S.; Scott, A.M.; Simpson, R.J. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods, 2012, 56(2), 293-304.
[http://dx.doi.org/10.1016/j.ymeth.2012.01.002] [PMID: 22285593]

Monguió-Tortajada, M.; Gálvez-Montón, C.; Bayes-Genis, A.; Roura, S.; Borràs, F.E. Extracellular vesicle isolation methods: Rising impact of size-exclusion chromatography. Cell. Mol. Life Sci., 2019, 76(12), 2369-2382.
[http://dx.doi.org/10.1007/s00018-019-03071-y] [PMID: 30891621]

Busatto, S.; Giacomini, A.; Montis, C.; Ronca, R.; Bergese, P. Uptake Profiles of human serum exosomes by murine and human tumor cells through combined use of colloidal nanoplasmonics and flow cytofluorimetric analysis. Anal. Chem., 2018, 90(13), 7855-7861.
[http://dx.doi.org/10.1021/acs.analchem.7b04374] [PMID: 29870225]

Coumans, F.A.W.; Brisson, A.R.; Buzas, E.I.; Dignat-George, F.; Drees, E.E.E.; El-Andaloussi, S.; Emanueli, C.; Gasecka, A.; Hendrix, A.; Hill, A.F.; Lacroix, R.; Lee, Y.; van Leeuwen, T.G.; Mackman, N.; Mäger, I.; Nolan, J.P.; van der Pol, E.; Pegtel, D.M.; Sahoo, S.; Siljander, P.R.M.; Sturk, G.; de Wever, O.; Nieuwland, R. Methodological guidelines to study extracellular vesicles. Circ. Res., 2017, 120(10), 1632-1648.
[http://dx.doi.org/10.1161/CIRCRESAHA.117.309417] [PMID: 28495994]

Busatto, S.; Vilanilam, G.; Ticer, T.; Lin, W.L.; Dickson, D.; Shapiro, S.; Bergese, P.; Wolfram, J. Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid. Cells, 2018, 7(12), 273.
[http://dx.doi.org/10.3390/cells7120273] [PMID: 30558352]

Gao, J.; Dong, X.; Wang, Z. Generation, purification and engineering of extracellular vesicles and their biomedical applications. Methods, 2020, 177, 114-125.
[http://dx.doi.org/10.1016/j.ymeth.2019.11.012] [PMID: 31790730]

Shen, W.; Guo, K.; Adkins, G.B.; Jiang, Q.; Liu, Y.; Sedano, S.; Duan, Y.; Yan, W.; Wang, S.E.; Bergersen, K.; Worth, D.; Wilson, E.H.; Zhong, W. A single Extracellular Vesicle (EV) flow cytometry approach to reveal EV heterogeneity. Angew. Chem. Int. Ed., 2018, 57(48), 15675-15680.
[http://dx.doi.org/10.1002/anie.201806901] [PMID: 30291794]

Lobb, R.J.; Becker, M.; Wen, W. S.; Wong, C.S.F.; Wiegmans, A.P.; Leimgruber, A.; Möller, A. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J. Extracell. Vesicles, 2015, 4(1), 27031.
[http://dx.doi.org/10.3402/jev.v4.27031] [PMID: 26194179]

Pisitkun, T.; Shen, R.F.; Knepper, M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA, 2004, 101(36), 13368-13373.
[http://dx.doi.org/10.1073/pnas.0403453101] [PMID: 15326289]

Benmoussa, A.; Ly, S.; Shan, S.T.; Laugier, J.; Boilard, E.; Gilbert, C.; Provost, P. A subset of extracellular vesicles carries the bulk of microRNAs in commercial dairy cow’s milk. J. Extracell. Vesicles, 2017, 6(1), 1401897.
[http://dx.doi.org/10.1080/20013078.2017.1401897] [PMID: 29904572]

Skog, J.; Würdinger, T.; van Rijn, S.; Meijer, D.H.; Gainche, L.; Curry, W.T., Jr; Carter, B.S.; Krichevsky, A.M.; Breakefield, X.O.; Breakefield, X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol., 2008, 10(12), 1470-1476.
[http://dx.doi.org/10.1038/ncb1800] [PMID: 19011622]

Fu, Y.; Li, C.; Lu, S.; Zhou, W.; Tang, F.; Xie, X.S.; Huang, Y. Uniform and accurate single-cell sequencing based on emulsion whole-genome amplification. Proc. Natl. Acad. Sci., 2015, 112(38), 11923-11928.
[http://dx.doi.org/10.1073/pnas.1513988112] [PMID: 26340991]

Joshi, G.K.; Deitz-McElyea, S.; Liyanage, T.; Lawrence, K.; Mali, S.; Sardar, R.; Korc, M. Label-free nanoplasmonic-based short noncoding RNA sensing at attomolar concentrations allows for quantitative and highly specific assay of MicroRNA-10b in biological fluids and circulating exosomes. ACS Nano, 2015, 9(11), 11075-11089.
[http://dx.doi.org/10.1021/acsnano.5b04527] [PMID: 26444644]

Karimi, N.; Cvjetkovic, A.; Jang, S.C.; Crescitelli, R.; Hosseinpour Feizi, M.A.; Nieuwland, R.; Lötvall, J.; Lässer, C. Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins. Cell. Mol. Life Sci., 2018, 75(15), 2873-2886.
[http://dx.doi.org/10.1007/s00018-018-2773-4] [PMID: 29441425]

Szatanek, R.; Baj-Krzyworzeka, M.; Zimoch, J.; Lekka, M.; Siedlar, M.; Baran, J. The methods of choice for Extracellular Vesicles (EVs) characterization. Int. J. Mol. Sci., 2017, 18(6), 1153.
[http://dx.doi.org/10.3390/ijms18061153] [PMID: 28555055]

Soo, C.Y.; Song, Y.; Zheng, Y.; Campbell, E.C.; Riches, A.C.; Gunn-Moore, F.; Powis, S.J. Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology, 2012, 136(2), 192-197.
[http://dx.doi.org/10.1111/j.1365-2567.2012.03569.x] [PMID: 22348503]

Li, T.D.; Zhang, R.; Chen, H.; Huang, Z.P.; Ye, X.; Wang, H.; Deng, A.M.; Kong, J.L. An ultrasensitive polydopamine bi-functionalized SERS immunoassay for exosome-based diagnosis and classification of pancreatic cancer. Chem. Sci., 2018, 9(24), 5372-5382.
[http://dx.doi.org/10.1039/C8SC01611A] [PMID: 30009009]

Choi, D.; Montermini, L.; Jeong, H.; Sharma, S.; Meehan, B.; Rak, J. Mapping subpopulations of cancer cell-derived extracellular vesicles and particles by nano-flow cytometry. ACS Nano, 2019, 13(9), 10499-10511.
[http://dx.doi.org/10.1021/acsnano.9b04480] [PMID: 31469961]

Jin, M.Z.; Wang, X.P. Immunogenic cell death-based cancer vaccines. Front. Immunol., 2021, 12, 697964.
[http://dx.doi.org/10.3389/fimmu.2021.697964] [PMID: 34135914]

Luan, X.; Sansanaphongpricha, K.; Myers, I.; Chen, H.; Yuan, H.; Sun, D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol. Sin., 2017, 38(6), 754-763.
[http://dx.doi.org/10.1038/aps.2017.12] [PMID: 28392567]

Lu, M.; Huang, Y. Bioinspired exosome-like therapeutics and delivery nanoplatforms. Biomaterials, 2020, 242, 119925.
[http://dx.doi.org/10.1016/j.biomaterials.2020.119925] [PMID: 32151860]

Kim, M.S.; Haney, M.J.; Zhao, Y.; Mahajan, V.; Deygen, I.; Klyachko, N.L.; Inskoe, E.; Piroyan, A.; Sokolsky, M.; Okolie, O.; Hingtgen, S.D.; Kabanov, A.V.; Batrakova, E.V. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine, 2016, 12(3), 655-664.
[http://dx.doi.org/10.1016/j.nano.2015.10.012] [PMID: 26586551]

O’Loughlin, A.J.; Mäger, I.; de Jong, O.G.; Varela, M.A.; Schiffelers, R.M.; El Andaloussi, S.; Wood, M.J.A.; Vader, P. Functional delivery of lipid-conjugated siRNA by extracellular vesicles. Mol. Ther., 2017, 25(7), 1580-1587.
[http://dx.doi.org/10.1016/j.ymthe.2017.03.021] [PMID: 28392161]

Wu, P.; Zhang, B.; Ocansey, D.K.W.; Xu, W.; Qian, H. Extracellular vesicles: A bright star of nanomedicine. Biomaterials, 2021, 269, 120467.
[http://dx.doi.org/10.1016/j.biomaterials.2020.120467] [PMID: 33189359]

Ye, Z.; Zhang, T.; He, W.; Jin, H.; Liu, C.; Yang, Z.; Ren, J. Methotrexate-loaded extracellular vesicles functionalized with therapeutic and targeted peptides for the treatment of glioblastoma multiforme. ACS Appl. Mater. Interfaces, 2018, 10(15), 12341-12350.
[http://dx.doi.org/10.1021/acsami.7b18135] [PMID: 29564886]

Didiot, M.C.; Hall, L.M.; Coles, A.H.; Haraszti, R.A.; Godinho, B.M.D.C.; Chase, K.; Sapp, E.; Ly, S.; Alterman, J.F.; Hassler, M.R.; Echeverria, D.; Raj, L.; Morrissey, D.V.; DiFiglia, M.; Aronin, N.; Khvorova, A. Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing. Mol. Ther., 2016, 24(10), 1836-1847.
[http://dx.doi.org/10.1038/mt.2016.126] [PMID: 27506293]

Haney, M.J.; Klyachko, N.L.; Zhao, Y.; Gupta, R.; Plotnikova, E.G.; He, Z.; Patel, T.; Piroyan, A.; Sokolsky, M.; Kabanov, A.V.; Batrakova, E.V. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J. Control. Release, 2015, 207, 18-30.
[http://dx.doi.org/10.1016/j.jconrel.2015.03.033] [PMID: 25836593]

Sato, Y.T.; Umezaki, K.; Sawada, S.; Mukai, S.; Sasaki, Y.; Harada, N.; Shiku, H.; Akiyoshi, K. Engineering hybrid exosomes by membrane fusion with liposomes. Sci. Rep., 2016, 6(1), 21933.
[http://dx.doi.org/10.1038/srep21933] [PMID: 26911358]

Doskocz, J. Dałek, P.; Przybyło, M.; Trzebicka, B.; Foryś A.; Kobyliukh, A.; Iglič A.; Langner, M. The elucidation of the molecular mechanism of the extrusion process. Materials (Basel), 2021, 14(15), 4278.
[http://dx.doi.org/10.3390/ma14154278] [PMID: 34361472]

Nele, V.; Holme, M.N.; Kauscher, U.; Thomas, M.R.; Doutch, J.J.; Stevens, M.M. Effect of formulation method, lipid composition, and PEGylation on vesicle lamellarity: A small-angle neutron scattering study. Langmuir, 2019, 35(18), 6064-6074.
[http://dx.doi.org/10.1021/acs.langmuir.8b04256] [PMID: 30977658]

Wang, T.; Larcher, L.; Ma, L.; Veedu, R. Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides. Molecules, 2018, 23(10), 2564.
[http://dx.doi.org/10.3390/molecules23102564] [PMID: 30297632]

Morrissey, M.A.; Sherwood, D.R. An active role for basement membrane assembly and modification in tissue sculpting. J. Cell.Sci., 2015, 128(9), 168021.
[http://dx.doi.org/10.1242/jcs.168021] [PMID: 25717004]

Huttner, W.B.; Schmidt, A. Lipids, lipid modification and lipid–protein interaction in membrane budding and fission — insights from the roles of endophilin A1 and synaptophysin in synaptic vesicle endocytosis. Curr. Opin. Neurobiol., 2000, 10(5), 543-551.
[http://dx.doi.org/10.1016/S0959-4388(00)00126-4] [PMID: 11084315]

Wu, L.; Liu, M.; Zhu, X.; Shan, W.; Huang, Y. Modification strategies of lipid-based nanocarriers for mucosal drug delivery. Curr. Pharm. Des., 2015, 21(36), 5198-5211.
[http://dx.doi.org/10.2174/1381612821666150923103000] [PMID: 26412355]

Zhuang, W.R.; Wang, Y.; Lei, Y.; Zuo, L.; Jiang, A.; Wu, G.; Nie, W.; Huang, L.L.; Xie, H.Y. Phytochemical engineered bacterial outer membrane vesicles for photodynamic effects promoted immunotherapy. Nano Lett., 2022, 22(11), 4491-4500.
[http://dx.doi.org/10.1021/acs.nanolett.2c01280] [PMID: 35605283]

Tian, T.; Zhang, H.X.; He, C.P.; Fan, S.; Zhu, Y.L.; Qi, C.; Huang, N.P.; Xiao, Z.D.; Lu, Z.H.; Tannous, B.A.; Gao, J. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials, 2018, 150, 137-149.
[http://dx.doi.org/10.1016/j.biomaterials.2017.10.012] [PMID: 29040874]

Li, T.; Yang, J.; Liu, R.; Yi, Y.; Huang, M.; Wu, Y.; Tu, H.; Zhang, L. Efficient fabrication of reversible pH-induced carboxymethyl chitosan nanoparticles for antitumor drug delivery under weakly acidic microenvironment. Int. J. Biol. Macromol., 2019, 126, 68-73.
[http://dx.doi.org/10.1016/j.ijbiomac.2018.12.178] [PMID: 30579898]

Rinaldi, F.; Hanieh, P.N.; Del Favero, E.; Rondelli, V.; Brocca, P.; Pereira, M.C.; Andreev, O.A.; Reshetnyak, Y.K.; Marianecci, C.; Carafa, M. Decoration of nanovesicles with pH (Low) Insertion Peptide (pHLIP) for targeted delivery. Nanoscale Res. Lett., 2018, 13(1), 391.
[http://dx.doi.org/10.1186/s11671-018-2807-8] [PMID: 30515583]

Jia, G.; Han, Y.; An, Y.; Ding, Y.; He, C.; Wang, X.; Tang, Q. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials, 2018, 178, 302-316.
[http://dx.doi.org/10.1016/j.biomaterials.2018.06.029] [PMID: 29982104]

Gao, J.; Wang, S.; Dong, X.; Wang, Z. RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy via multiple tumorous targeting. Theranostics, 2021, 11(7), 3301-3316.
[http://dx.doi.org/10.7150/thno.51988] [PMID: 33537088]

Wang, Q.X.; Chen, X.; Li, Z.L.; Gong, Y.C.; Xiong, X.Y. Transferrin/folate dual-targeting Pluronic F127/poly(lactic acid) polymersomes for effective anticancer drug delivery. J. Biomater. Sci. Polym. Ed., 2022, 33(9), 1140-1156.
[http://dx.doi.org/10.1080/09205063.2022.2044434] [PMID: 35179085]

Kim, W.; Lee, E.J.; Bae, I.H.; Myoung, K.; Kim, S.T.; Park, P.J.; Lee, K.H.; Pham, A.V.Q.; Ko, J.; Oh, S.H.; Cho, E.G. Lactobacillus plantarum ‐derived extracellular vesicles induce anti‐inflammatory M2 macrophage polarization in vitro. J. Extracell. Vesicles, 2020, 9(1), 1793514.
[http://dx.doi.org/10.1080/20013078.2020.1793514] [PMID: 32944181]

He, J.; Huo, Y.; Zhang, Z.; Luo, Y.; Liu, X.; Chen, Q.; Wu, P.; Shi, W.; Wu, T.; Tang, C.; Wang, H.; Li, L.; Liu, X.; Huang, Y.; Zhao, Y.; Gan, L.; Wang, B.; Zhong, L. Generation of αGal-enhanced bifunctional tumor vaccine. Acta Pharm. Sin. B, 2022, 12(7), 3177-3186.
[http://dx.doi.org/10.1016/j.apsb.2022.03.002] [PMID: 35865091]

Xu, Y.; Feng, K.; Zhao, H.; Di, L.; Wang, L.; Wang, R. Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment. Theranostics, 2022, 12(4), 1683-1714.
[http://dx.doi.org/10.7150/thno.67775] [PMID: 35198064]

Liu, H.; Chen, L.; Peng, Y.; Yu, S.; Liu, J.; Wu, L.; Zhang, L.; Wu, Q.; Chang, X.; Yu, X.; Liu, T. Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy. Oncotarget, 2018, 9(2), 2887-2894.
[http://dx.doi.org/10.18632/oncotarget.20812] [PMID: 29416821]

Guo, M.; Wu, F.; Hu, G.; Chen, L.; Xu, J.; Xu, P.; Wang, X.; Li, Y.; Liu, S.; Zhang, S.; Huang, Q.; Fan, J.; Lv, Z.; Zhou, M.; Duan, L.; Liao, T.; Yang, G.; Tang, K.; Liu, B.; Liao, X.; Tao, X.; Jin, Y. Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion. Sci. Transl. Med., 2019, 11(474), eaat5690.
[http://dx.doi.org/10.1126/scitranslmed.aat5690] [PMID: 30626714]

Pardoll, D.M. Cancer vaccines. Nat. Med., 1998, 4(S5), 525-531.
[http://dx.doi.org/10.1038/nm0598supp-525] [PMID: 9585204]

Morse, M.A.; Chui, S.; Hobeika, A.; Lyerly, H.K.; Clay, T. Recent developments in therapeutic cancer vaccines. Nat. Clin. Pract. Oncol., 2005, 2(2), 108-113.
[http://dx.doi.org/10.1038/ncponc0098] [PMID: 16264883]

Blass, E.; Ott, P.A. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines. Nat. Rev. Clin. Oncol., 2021, 18(4), 215-229.
[http://dx.doi.org/10.1038/s41571-020-00460-2] [PMID: 33473220]

Lee, E.Y.; Park, K.S.; Yoon, Y.J.; Lee, J.; Moon, H.G.; Jang, S.C.; Choi, K.H.; Kim, Y.K.; Gho, Y.S. Therapeutic effects of autologous tumor-derived nanovesicles on melanoma growth and metastasis. PLoS One, 2012, 7(3), e33330.
[http://dx.doi.org/10.1371/journal.pone.0033330] [PMID: 22438914]

Wang, C.; Huang, X.; Wu, Y.; Wang, J.; Li, F.; Guo, G. Tumor cell-associated exosomes robustly elicit anti-tumor immune responses through modulating dendritic cell vaccines in lung tumor. Int. J. Biol. Sci., 2020, 16(4), 633-643.
[http://dx.doi.org/10.7150/ijbs.38414] [PMID: 32025211]

Liu, B.; Yang, Y.; Chao, Y.; Xiao, Z.; Xu, J.; Wang, C.; Dong, Z.; Hou, L.; Li, Q.; Liu, Z. Equipping cancer cell membrane vesicles with functional DNA as a targeted vaccine for cancer immunotherapy. Nano Lett., 2021, 21(22), 9410-9418.
[http://dx.doi.org/10.1021/acs.nanolett.1c02582] [PMID: 34730968]

Wu, A.Y.T.; Sung, Y.C.; Chen, Y.J.; Chou, S.T.Y.; Guo, V.; Chien, J.C.Y.; Ko, J.J.S.; Yang, A.L.; Huang, H.C.; Chuang, J.C.; Wu, S.; Ho, M.R.; Ericsson, M.; Lin, W.W.; Cheung, C.H.Y.; Juan, H.F.; Ueda, K.; Chen, Y.; Lai, C.P.K. Multiresolution imaging using bioluminescence resonance energy transfer identifies distinct biodistribution profiles of extracellular vesicles and exomeres with redirected tropism. Adv. Sci., 2020, 7(19), 2001467.
[http://dx.doi.org/10.1002/advs.202001467] [PMID: 33042758]

Garofalo, M.; Villa, A.; Brunialti, E.; Crescenti, D.; Dell’Omo, G.; Kuryk, L.; Vingiani, A.; Mazzaferro, V.; Ciana, P. Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation. Nanotheranostics, 2021, 5(1), 1-7.
[http://dx.doi.org/10.7150/ntno.47226] [PMID: 33391971]

Hu, M.; Zhang, J.; Kong, L.; Yu, Y.; Hu, Q.; Yang, T.; Wang, Y.; Tu, K.; Qiao, Q.; Qin, X.; Zhang, Z. Immunogenic hybrid nanovesicles of liposomes and tumor-derived nanovesicles for cancer immunochemotherapy. ACS Nano, 2021, 15(2), 3123-3138.
[http://dx.doi.org/10.1021/acsnano.0c09681] [PMID: 33470095]

Gupta, P.; Kadamberi, I.P.; Mittal, S.; Tsaih, S.W.; George, J.; Kumar, S.; Vijayan, D.K.; Geethadevi, A.; Parashar, D.; Topchyan, P.; McAlarnen, L.; Volkman, B.F.; Cui, W.; Zhang, K.Y.J.; Di Vizio, D.; Chaluvally-Raghavan, P.; Pradeep, S. Tumor derived extracellular vesicles drive T Cell exhaustion in tumor microenvironment through sphingosine mediated signaling and impacting immunotherapy outcomes in ovarian cancer. Adv. Sci., 2022, 9(14), 2104452.
[http://dx.doi.org/10.1002/advs.202104452] [PMID: 35289120]

Cui, Y.; Wang, D.; Xie, M. Tumor-derived extracellular vesicles promote activation of carcinoma-associated fibroblasts and facilitate invasion and metastasis of ovarian cancer by carrying miR-630. Front. Cell Dev. Biol., 2021, 9, 652322.
[http://dx.doi.org/10.3389/fcell.2021.652322] [PMID: 34277601]

Aslan, C.; Maralbashi, S.; Salari, F.; Kahroba, H.; Sigaroodi, F.; Kazemi, T.; Kharaziha, P. Tumor‐derived exosomes: Implication in angiogenesis and antiangiogenesis cancer therapy. J. Cell. Physiol., 2019, 234(10), 16885-16903.
[http://dx.doi.org/10.1002/jcp.28374] [PMID: 30793767]

Peixoto da Silva, S.; Caires, H.R.; Bergantim, R.; Guimarães, J.E.; Vasconcelos, M.H. miRNAs mediated drug resistance in hematological malignancies. Semin. Cancer Biol., 2021, 83, 283-302.
[PMID: 33757848]

Whiteside, T.L.; Diergaarde, B.; Hong, C.S. Tumor-Derived Exosomes (TEX) and their role in immuno-oncology. Int. J. Mol. Sci., 2021, 22(12), 6234.
[http://dx.doi.org/10.3390/ijms22126234] [PMID: 34207762]

Morrissey, S.M.; Zhang, F.; Ding, C.; Montoya-Durango, D.E.; Hu, X.; Yang, C.; Wang, Z.; Yuan, F.; Fox, M.; Zhang, H.; Guo, H.; Tieri, D.; Kong, M.; Watson, C.T.; Mitchell, R.A.; Zhang, X.; McMasters, K.M.; Huang, J.; Yan, J. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab., 2021, 33(10), 2040-2058.e10.
[http://dx.doi.org/10.1016/j.cmet.2021.09.002] [PMID: 34559989]

Cheng, L.; Zhang, X.; Tang, J.; Lv, Q.; Liu, J. Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy. Biomaterials, 2021, 275, 120964.
[http://dx.doi.org/10.1016/j.biomaterials.2021.120964] [PMID: 34147721]

Tao, H.; Chen, X.; Cao, H.; Zheng, L.; Li, Q.; Zhang, K.; Han, Z.; Han, Z.C.; Guo, Z.; Li, Z.; Wang, L. Mesenchymal stem cell-derived extracellular vesicles for corneal wound repair. Stem Cells Int., 2019, 2019, 5738510.
[http://dx.doi.org/10.1155/2019/5738510] [PMID: 31885617]

Wang, X.; Thomsen, P. Mesenchymal stem cell–derived small extracellular vesicles and bone regeneration. Basic Clin. Pharmacol. Toxicol., 2021, 128(1), 18-36.
[http://dx.doi.org/10.1111/bcpt.13478] [PMID: 32780530]

Keshtkar, S.; Azarpira, N.; Ghahremani, M.H. Mesenchymal stem cell-derived extracellular vesicles: Novel frontiers in regenerative medicine. Stem Cell Res. Ther., 2018, 9(1), 63.
[http://dx.doi.org/10.1186/s13287-018-0791-7] [PMID: 29523213]

Zhang, B.; Tian, X.; Hao, J.; Xu, G.; Zhang, W. Mesenchymal stem cell-derived extracellular vesicles in tissue regeneration. Cell Transplant., 2020, 29, 963689720908500.
[http://dx.doi.org/10.1177/0963689720908500] [PMID: 32207341]

Zhao, Q.; Hai, B.; Zhang, X.; Xu, J.; Koehler, B.; Liu, F. Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer. Nanomedicine, 2020, 24, 102146.
[http://dx.doi.org/10.1016/j.nano.2019.102146] [PMID: 31884039]

Azizi, S.A.; Stokes, D.; Augelli, B.J.; DiGirolamo, C.; Prockop, D.J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA, 1998, 95(7), 3908-3913.
[http://dx.doi.org/10.1073/pnas.95.7.3908] [PMID: 9520466]

Aboody, K.S.; Brown, A.; Rainov, N.G.; Bower, K.A.; Liu, S.; Yang, W.; Small, J.E.; Herrlinger, U.; Ourednik, V.; Black, P.M.; Breakefield, X.O.; Snyder, E.Y. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc. Natl. Acad. Sci., 2000, 97(23), 12846-12851.
[http://dx.doi.org/10.1073/pnas.97.23.12846] [PMID: 11070094]

Gao, J.; Dennis, J.E.; Muzic, R.F.; Lundberg, M.; Caplan, A.I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs, 2001, 169(1), 12-20.
[http://dx.doi.org/10.1159/000047856] [PMID: 11340257]

Zhang, H.; Feng, Y.; Xie, X.; Song, T.; Yang, G.; Su, Q.; Li, T.; Li, S.; Wu, C.; You, F.; Liu, Y.; Yang, H. Engineered mesenchymal stem cells as a biotherapy platform for targeted photodynamic immunotherapy of breast cancer. Adv. Healthc. Mater., 2022, 11(6), 2101375.
[http://dx.doi.org/10.1002/adhm.202101375] [PMID: 34981675]

Krysko, D.V.; Garg, A.D.; Kaczmarek, A.; Krysko, O.; Agostinis, P.; Vandenabeele, P. Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer, 2012, 12(12), 860-875.
[http://dx.doi.org/10.1038/nrc3380] [PMID: 23151605]

Zhou, W.; Zhou, Y.; Chen, X.; Ning, T.; Chen, H.; Guo, Q.; Zhang, Y.; Liu, P.; Zhang, Y.; Li, C.; Chu, Y.; Sun, T.; Jiang, C. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials, 2021, 268, 120546.
[http://dx.doi.org/10.1016/j.biomaterials.2020.120546] [PMID: 33253966]

Mahasa, K.J.; de Pillis, L.; Ouifki, R.; Eladdadi, A.; Maini, P.; Yoon, A.R.; Yun, C.O. Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy. Sci. Rep., 2020, 10(1), 425.
[http://dx.doi.org/10.1038/s41598-019-57240-x] [PMID: 31949228]

Ouyang, X.; Liu, Y.; Zhou, Y.; Guo, J.; Wei, T.T.; Liu, C.; Lee, B.; Chen, B.; Zhang, A.; Casey, K.M.; Wang, L.; Kooreman, N.G.; Habtezion, A.; Engleman, E.G.; Wu, J.C. Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. Stem Cell Reports, 2021, 16(6), 1468-1477.
[http://dx.doi.org/10.1016/j.stemcr.2021.04.004] [PMID: 33961792]

Wang, L.; Pegram, M.D.; Wu, J.C. Induced pluripotent stem cells as a novel cancer vaccine. Expert Opin. Biol. Ther., 2019, 19(11), 1191-1197.
[http://dx.doi.org/10.1080/14712598.2019.1650909] [PMID: 31364894]

Kooreman, N.G.; Kim, Y.; de Almeida, P.E.; Termglinchan, V.; Diecke, S.; Shao, N.Y.; Wei, T.T.; Yi, H.; Dey, D.; Nelakanti, R.; Brouwer, T.P.; Paik, D.T.; Sagiv-Barfi, I.; Han, A.; Quax, P.H.A.; Hamming, J.F.; Levy, R.; Davis, M.M.; Wu, J.C. Autologous iPSC-based vaccines elicit anti-tumor responses in vivo. Cell Stem Cell, 2018, 22(4), 501-513.e7.
[http://dx.doi.org/10.1016/j.stem.2018.01.016] [PMID: 29456158]

Tian, X.; Shen, H.; Li, Z.; Wang, T.; Wang, S. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment. J. Hematol. Oncol., 2019, 12(1), 84.
[http://dx.doi.org/10.1186/s13045-019-0772-z] [PMID: 31438991]

Wang, Y.; Lu, J.; Chen, L.; Bian, H.; Hu, J.; Li, D.; Xia, C.; Xu, H. Tumor-derived EV-Encapsulated miR-181b-5p induces angiogenesis to foster tumorigenesis and metastasis of ESCC. Mol. Ther. Nucleic Acids, 2020, 20, 421-437.
[http://dx.doi.org/10.1016/j.omtn.2020.03.002] [PMID: 32244169]

Montecalvo, A.; Shufesky, W.J.; Stolz, D.B.; Sullivan, M.G.; Wang, Z.; Divito, S.J.; Papworth, G.D.; Watkins, S.C.; Robbins, P.D.; Larregina, A.T.; Morelli, A.E. Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J. Immunol., 2008, 180(5), 3081-3090.
[http://dx.doi.org/10.4049/jimmunol.180.5.3081]

Zitvogel, L.; Regnault, A.; Lozier, A.; Wolfers, J.; Flament, C.; Tenza, D.; Ricciardi-Castagnoli, P.; Raposo, G.; Amigorena, S. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell derived exosomes. Nat. Med., 1998, 4(5), 594-600.
[http://dx.doi.org/10.1038/nm0598-594] [PMID: 9585234]

Jung, M.; Kang, M.; Kim, B.S.; Hong, J.; Kim, C.; Koh, C.H.; Choi, G.; Chung, Y.; Kim, B.S. Nanovesicle‐mediated targeted delivery of immune checkpoint blockades to potentiate therapeutic efficacy and prevent side effects. Adv. Mater., 2022, 34(9), 2106516.
[http://dx.doi.org/10.1002/adma.202106516] [PMID: 34962660]

Besse, B.; Charrier, M.; Lapierre, V.; Dansin, E.; Lantz, O.; Planchard, D.; Le Chevalier, T.; Livartoski, A.; Barlesi, F.; Laplanche, A.; Ploix, S.; Vimond, N.; Peguillet, I.; Théry, C.; Lacroix, L.; Zoernig, I.; Dhodapkar, K.; Dhodapkar, M.; Viaud, S.; Soria, J.C.; Reiners, K.S.; Pogge von Strandmann, E.; Vély, F.; Rusakiewicz, S.; Eggermont, A.; Pitt, J.M.; Zitvogel, L.; Chaput, N. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. OncoImmunology, 2016, 5(4), e1071008.
[http://dx.doi.org/10.1080/2162402X.2015.1071008] [PMID: 27141373]

Pitt, J.M.; André, F.; Amigorena, S.; Soria, J.C.; Eggermont, A.; Kroemer, G.; Zitvogel, L. Dendritic cell–derived exosomes for cancer therapy. J. Clin. Invest., 2016, 126(4), 1224-1232.
[http://dx.doi.org/10.1172/JCI81137] [PMID: 27035813]

Hong, J. Kang, M.; Jung, M.; Lee, Y.Y.; Cho, Y.; Kim, C.; Song, S.Y.; Park, C.G.; Doh, J.; Kim, B.S. T‐Cell‐Derived nanovesicles for cancer immunotherapy. Adv. Mater., 2021, 33(33), 2101110.
[http://dx.doi.org/10.1002/adma.202101110] [PMID: 34235790]

Schmidts, A.; Maus, M.V. Making CAR T cells a solid option for solid tumors. Front. Immunol., 2018, 9, 2593.
[http://dx.doi.org/10.3389/fimmu.2018.02593] [PMID: 30467505]

Chen, K.; Wang, S.; Qi, D.; Ma, P.; Fang, Y.; Jiang, N.; Wu, E.; Li, N. Clinical investigations of CAR-T cell therapy for solid tumors. Front. Immunol., 2022, 13, 896685.
[http://dx.doi.org/10.3389/fimmu.2022.896685] [PMID: 35924243]

Federici, C.; Shahaj, E.; Cecchetti, S.; Camerini, S.; Casella, M.; Iessi, E.; Camisaschi, C.; Paolino, G.; Calvieri, S.; Ferro, S.; Cova, A.; Squarcina, P.; Bertuccini, L.; Iosi, F.; Huber, V.; Lugini, L. Natural-Killer-Derived extracellular vesicles: Immune sensors and interactors. Front. Immunol., 2020, 11, 262.
[http://dx.doi.org/10.3389/fimmu.2020.00262] [PMID: 32231660]

Kang, Y.T.; Niu, Z.; Hadlock, T.; Purcell, E.; Lo, T.W.; Zeinali, M.; Owen, S.; Keshamouni, V.G.; Reddy, R.; Ramnath, N.; Nagrath, S. On‐Chip biogenesis of circulating NK cell‐derived exosomes in non‐small cell lung cancer exhibits antitumoral activity. Adv. Sci., 2021, 8(6), 2003747.
[http://dx.doi.org/10.1002/advs.202003747] [PMID: 33747745]

Choo, Y.W.; Kang, M.; Kim, H.Y.; Han, J.; Kang, S.; Lee, J.R.; Jeong, G.J.; Kwon, S.P.; Song, S.Y.; Go, S.; Jung, M.; Hong, J.; Kim, B.S. M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors. ACS Nano, 2018, 12(9), 8977-8993.
[http://dx.doi.org/10.1021/acsnano.8b02446] [PMID: 30133260]

Wang, Y.; Gong, X.; Li, J.; Wang, H.; Xu, X.; Wu, Y.; Wang, J.; Wang, S.; Li, Y.; Zhang, Z. M2 macrophage microvesicle-inspired nanovehicles improve accessibility to cancer cells and cancer stem cells in tumors. J. Nanobiotechnology, 2021, 19(1), 397.
[http://dx.doi.org/10.1186/s12951-021-01143-5] [PMID: 34838042]

Beveridge, T.J. Structures of gram-negative cell walls and their derived membrane vesicles. J. Bacteriol., 1999, 181(16), 4725-4733.
[http://dx.doi.org/10.1128/JB.181.16.4725-4733.1999] [PMID: 10438737]

Lapinet, J.A.; Scapini, P.; Calzetti, F.; Pérez, O.; Cassatella, M.A. Gene expression and production of tumor necrosis factor alpha, interleukin-1beta (IL-1beta), IL-8, macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, and gamma interferon-inducible protein 10 by human neutrophils stimulated with group B meningococcal outer membrane vesicles. Infect. Immun., 2000, 68(12), 6917-6923.
[http://dx.doi.org/10.1128/IAI.68.12.6917-6923.2000] [PMID: 11083814]

Jäger, J.; Marwitz, S.; Tiefenau, J.; Rasch, J.; Shevchuk, O.; Kugler, C.; Goldmann, T.; Steinert, M. Human lung tissue explants reveal novel interactions during Legionella pneumophila infections. Infect. Immun., 2014, 82(1), 275-285.
[http://dx.doi.org/10.1128/IAI.00703-13] [PMID: 24166955]

Alaniz, R.C.; Deatherage, B.L.; Lara, J.C.; Cookson, B.T. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol., 2007, 179(11), 7692-7701.
[http://dx.doi.org/10.4049/jimmunol.179.11.7692]

Coffman, R.L.; Sher, A.; Seder, R.A. Vaccine adjuvants: Putting innate immunity to work. Immunity, 2010, 33(4), 492-503.
[http://dx.doi.org/10.1016/j.immuni.2010.10.002] [PMID: 21029960]

Wang, S.; Gao, J.; Wang, Z. Outer membrane vesicles for vaccination and targeted drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2019, 11(2), e1523.
[http://dx.doi.org/10.1002/wnan.1523] [PMID: 29701017]

Pan, J.; Li, X.; Shao, B.; Xu, F.; Huang, X.; Guo, X.; Zhou, S. Self‐blockade of PD‐L1 with bacteria‐derived outer‐membrane vesicle for enhanced cancer immunotherapy. Adv. Mater., 2022, 34(7), 2106307.
[http://dx.doi.org/10.1002/adma.202106307] [PMID: 34859919]

Wang, S.; Gao, J.; Li, M.; Wang, L.; Wang, Z. A facile approach for development of a vaccine made of bacterial double-layered membrane vesicles (DMVs). Biomaterials, 2018, 187, 28-38.
[http://dx.doi.org/10.1016/j.biomaterials.2018.09.042] [PMID: 30292939]

Schwechheimer, C.; Kuehn, M.J. Outer-membrane vesicles from Gram-negative bacteria: Biogenesis and functions. Nat. Rev. Microbiol., 2015, 13(10), 605-619.
[http://dx.doi.org/10.1038/nrmicro3525] [PMID: 26373371]

Peng, L.H.; Wang, M.Z.; Chu, Y.; Zhang, L.; Niu, J.; Shao, H.T.; Yuan, T.J.; Jiang, Z.H.; Gao, J.Q.; Ning, X.H. Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL–programmed therapy against melanoma. Sci. Adv., 2020, 6(27), eaba2735.
[http://dx.doi.org/10.1126/sciadv.aba2735] [PMID: 32923586]

Cheng, K.; Zhao, R.; Li, Y.; Qi, Y.; Wang, Y.; Zhang, Y.; Qin, H.; Qin, Y.; Chen, L.; Li, C.; Liang, J.; Li, Y.; Xu, J.; Han, X.; Anderson, G.J.; Shi, J.; Ren, L.; Zhao, X.; Nie, G. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology. Nat. Commun., 2021, 12(1), 2041.
[http://dx.doi.org/10.1038/s41467-021-22308-8] [PMID: 33824314]

Huang, Y.; Nieh, M.P.; Chen, W.; Lei, Y. Outer membrane vesicles (OMVs) enabled bio‐applications: A critical review. Biotechnol. Bioeng., 2022, 119(1), 34-47.
[http://dx.doi.org/10.1002/bit.27965] [PMID: 34698385]

Zou, M.Z.; Li, Z.H.; Bai, X.F.; Liu, C.J.; Zhang, X.Z. Hybrid vesicles based on autologous tumor cell membrane and bacterial outer membrane to enhance innate immune response and personalized tumor immunotherapy. Nano Lett., 2021, 21(20), 8609-8618.
[http://dx.doi.org/10.1021/acs.nanolett.1c02482] [PMID: 34661419]

Zhao, P.; Xu, Y.; Ji, W.; Li, L.; Qiu, L.; Zhou, S.; Qian, Z.; Zhang, H. Hybrid membrane nanovaccines combined with immune checkpoint blockade to enhance cancer immunotherapy. Int. J. Nanomed., 2022, 17, 73-89.
[http://dx.doi.org/10.2147/IJN.S346044] [PMID: 35027827]

Majeti, R.; Chao, M.P.; Alizadeh, A.A.; Pang, W.W.; Jaiswal, S.; Gibbs, K.D.; van Rooijen, N.; Weissman, I.L. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell, 2009, 138(2), 286-299.
[http://dx.doi.org/10.1016/j.cell.2009.05.045] [PMID: 19632179]

Jaiswal, S.; Jamieson, C.H.M.; Pang, W.W.; Park, C.Y.; Chao, M.P.; Majeti, R.; Traver, D.; van Rooijen, N.; Weissman, I.L. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell, 2009, 138(2), 271-285.
[http://dx.doi.org/10.1016/j.cell.2009.05.046] [PMID: 19632178]

Chen, L.; Han, X. Anti–PD-1/PD-L1 therapy of human cancer: Past, present, and future. J. Clin. Invest., 2015, 125(9), 3384-3391.
[http://dx.doi.org/10.1172/JCI80011] [PMID: 26325035]

Meng, Q.F.; Zhao, Y.; Dong, C.; Liu, L.; Pan, Y.; Lai, J.; Liu, Z.; Yu, G.T.; Chen, X.; Rao, L. Genetically programmable fusion cellular vesicles for cancer immunotherapy. Angew. Chem. Int. Ed., 2021, 60(50), 26320-26326.
[http://dx.doi.org/10.1002/anie.202108342] [PMID: 34661332]

Van Deun, J.; Mestdagh, P.; Agostinis, P.; Akay, Ö.; Anand, S.; Anckaert, J.; Martinez, Z.A.; Baetens, T.; Beghein, E.; Bertier, L.; Berx, G.; Boere, J.; Boukouris, S.; Bremer, M.; Buschmann, D.; Byrd, J.B.; Casert, C.; Cheng, L.; Cmoch, A.; Daveloose, D.; De Smedt, E.; Demirsoy, S.; Depoorter, V.; Dhondt, B.; Driedonks, T.A.P.; Dudek, A.; Elsharawy, A.; Floris, I.; Foers, A.D.; Gärtner, K.; Garg, A.D.; Geeurickx, E.; Gettemans, J.; Ghazavi, F.; Giebel, B.; Kormelink, T.G.; Hancock, G.; Helsmoortel, H.; Hill, A.F.; Hyenne, V.; Kalra, H.; Kim, D.; Kowal, J.; Kraemer, S.; Leidinger, P.; Leonelli, C.; Liang, Y.; Lippens, L.; Liu, S.; Lo Cicero, A.; Martin, S.; Mathivanan, S.; Mathiyalagan, P.; Matusek, T.; Milani, G.; Monguió-Tortajada, M.; Mus, L.M.; Muth, D.C.; Németh, A.; Nolte-’t Hoen, E.N.M.; O’Driscoll, L.; Palmulli, R.; Pfaffl, M.W.; Primdal-Bengtson, B.; Romano, E.; Rousseau, Q.; Sahoo, S.; Sampaio, N.; Samuel, M.; Scicluna, B.; Soen, B.; Steels, A.; Swinnen, J.V.; Takatalo, M.; Thaminy, S.; Théry, C.; Tulkens, J.; Van Audenhove, I.; van der Grein, S.; Van Goethem, A.; van Herwijnen, M.J.; Van Niel, G.; Van Roy, N.; Van Vliet, A.R.; Vandamme, N.; Vanhauwaert, S.; Vergauwen, G.; Verweij, F.; Wallaert, A.; Wauben, M.; Witwer, K.W.; Zonneveld, M.I.; De Wever, O.; Vandesompele, J.; Hendrix, A. EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods, 2017, 14(3), 228-232.
[http://dx.doi.org/10.1038/nmeth.4185] [PMID: 28245209]

Russell, A.E.; Sneider, A.; Witwer, K.W.; Bergese, P.; Bhattacharyya, S.N.; Cocks, A.; Cocucci, E.; Erdbrügger, U.; Falcon-Perez, J.M.; Freeman, D.W.; Gallagher, T.M.; Hu, S.; Huang, Y.; Jay, S.M.; Kano, S.; Lavieu, G.; Leszczynska, A.; Llorente, A.M.; Lu, Q.; Mahairaki, V.; Muth, D.C.; Hooten, N.N.; Ostrowski, M.; Prada, I.; Sahoo, S.; Schøyen, T.H.; Sheng, L.; Tesch, D.; Van Niel, G.; Vandenbroucke, R.E.; Verweij, F.J.; Villar, A.V.; Wauben, M.; Wehman, A.M.; Yin, H.; Carter, D.R.F.; Vader, P. Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: An ISEV position paper arising from the ISEV membranes and EVs workshop. J. Extracell. Vesicles, 2019, 8(1), 1684862.
[http://dx.doi.org/10.1080/20013078.2019.1684862] [PMID: 31762963]

Tan, K.; Li, R.; Huang, X.; Liu, Q. Outer membrane vesicles: Current status and future direction of these novel vaccine adjuvants. Front. Microbiol., 2018, 9, 783.
[http://dx.doi.org/10.3389/fmicb.2018.00783] [PMID: 29755431]

Jiang, X.C.; Zhang, T.; Gao, J.Q. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system. Adv. Drug Deliv. Rev., 2022, 187, 114324.
[http://dx.doi.org/10.1016/j.addr.2022.114324] [PMID: 35640803]

Liu, C.; Wang, Y.; Li, L.; He, D.; Chi, J.; Li, Q.; Wu, Y.; Zhao, Y.; Zhang, S.; Wang, L.; Fan, Z.; Liao, Y. Engineered extracellular vesicles and their mimetics for cancer immunotherapy. J. Control. Release, 2022, 349, 679-698.
[http://dx.doi.org/10.1016/j.jconrel.2022.05.062] [PMID: 35878728]

Ochyl, L.J.; Bazzill, J.D.; Park, C.; Xu, Y.; Kuai, R.; Moon, J.J. PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy. Biomaterials, 2018, 182, 157-166.
[http://dx.doi.org/10.1016/j.biomaterials.2018.08.016] [PMID: 30121425]

Tan, Y.N.; Huang, J.D.; Li, Y.P.; Li, S.S.; Luo, M.; Luo, J.; Lee, A.W.M.; Fu, L.; Hu, F.Q.; Guan, X.Y. Near‐infrared responsive membrane nanovesicles amplify homologous targeting delivery of Anti‐PD immunotherapy against metastatic tumors. Adv. Healthc. Mater., 2022, 11(6), 2101496.
[http://dx.doi.org/10.1002/adhm.202101496] [PMID: 34878725]

Bao, P.; Zheng, Z.T.; Ye, J.J.; Zhang, X.Z. Apoptotic body-mediated intracellular delivery strategy for enhanced STING activation and improved tumor immunogenicity. Nano Lett., 2022, 22(6), 2217-2227.
[http://dx.doi.org/10.1021/acs.nanolett.1c03996] [PMID: 35254071]

Osterman, C.J.D.; Lynch, J.C.; Leaf, P.; Gonda, A.; Ferguson Bennit, H.R.; Griffiths, D.; Wall, N.R. Curcumin modulates pancreatic adenocarcinoma cell-derived exosomal function. PLoS One, 2015, 10(7), e0132845.
[http://dx.doi.org/10.1371/journal.pone.0132845] [PMID: 26177391]

Zhou, Q.; Ding, W.; Qian, Z.; Zhu, Q.; Sun, C.; Yu, Q.; Tai, Z.; Xu, K. Immunotherapy strategy targeting programmed cell death ligand 1 and CD73 with macrophage-derived mimetic nanovesicles to treat bladder cancer. Mol. Pharm., 2021, 18(11), 4015-4028.
[http://dx.doi.org/10.1021/acs.molpharmaceut.1c00448] [PMID: 34648293]

Zhang, X.; Zhang, H.; Gu, J.; Zhang, J.; Shi, H.; Qian, H.; Wang, D.; Xu, W.; Pan, J.; Santos, H.A. Engineered extracellular vesicles for cancer therapy. Adv. Mater., 2021, 33(14), 2005709.
[http://dx.doi.org/10.1002/adma.202005709] [PMID: 33644908]

Hua, L.; Yang, Z.; Li, W.; Zhang, Q.; Ren, Z.; Ye, C.; Zheng, X.; Li, D.; Long, Q.; Bai, H.; Sun, W.; Yang, X.; Zheng, P.; He, J.; Chen, Y.; Huang, W.; Ma, Y. A novel immunomodulator delivery platform based on bacterial biomimetic vesicles for enhanced antitumor immunity. Adv. Mater., 2021, 33(43), 2103923.
[http://dx.doi.org/10.1002/adma.202103923] [PMID: 34510598]

Park, K.S.; Svennerholm, K.; Crescitelli, R.; Lässer, C.; Gribonika, I.; Lötvall, J. Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy. J. Extracell. Vesicles, 2021, 10(9), e12120.
[http://dx.doi.org/10.1002/jev2.12120] [PMID: 34262675]

Li, Y.; Zhao, R.; Cheng, K.; Zhang, K.; Wang, Y.; Zhang, Y.; Li, Y.; Liu, G.; Xu, J.; Xu, J.; Anderson, G.J.; Shi, J.; Ren, L.; Zhao, X.; Nie, G. Bacterial outer membrane vesicles presenting programmed death 1 for improved cancer immunotherapy via immune activation and checkpoint inhibition. ACS Nano, 2020, 14(12), 16698-16711.
[http://dx.doi.org/10.1021/acsnano.0c03776] [PMID: 33232124]

Huang, W.; Shu, C.; Hua, L.; Zhao, Y.; Xie, H.; Qi, J.; Gao, F.; Gao, R.; Chen, Y.; Zhang, Q.; Li, W.; Yuan, M.; Ye, C.; Ma, Y. Modified bacterial outer membrane vesicles induce autoantibodies for tumor therapy. Acta Biomater., 2020, 108, 300-312.
[http://dx.doi.org/10.1016/j.actbio.2020.03.030] [PMID: 32251780]

Li, Y.; Ma, X.; Yue, Y.; Zhang, K.; Cheng, K.; Feng, Q.; Ma, N.; Liang, J.; Zhang, T.; Zhang, L.; Chen, Z.; Wang, X.; Ren, L.; Zhao, X.; Nie, G. Rapid surface display of mrna antigens by bacteria‐derived outer membrane vesicles for a personalized tumor vaccine. Adv. Mater., 2022, 34(20), 2109984.
[http://dx.doi.org/10.1002/adma.202109984] [PMID: 35315546]

Li, L.; Miao, Q.; Meng, F.; Li, B.; Xue, T.; Fang, T.; Zhang, Z.; Zhang, J.; Ye, X.; Kang, Y.; Zhang, X.; Chen, Q.; Liang, X.; Chen, H.; Zhang, X. Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy. Theranostics, 2021, 11(12), 6033-6043.
[http://dx.doi.org/10.7150/thno.48868] [PMID: 33897897]

Chen, Q.; Huang, G.; Wu, W.; Wang, J.; Hu, J.; Mao, J.; Chu, P.K.; Bai, H.; Tang, G. A hybrid eukaryotic–prokaryotic nanoplatform with photothermal modality for enhanced antitumor vaccination. Adv. Mater., 2020, 32(16), 1908185.
[http://dx.doi.org/10.1002/adma.201908185] [PMID: 32108390]

Zhang, L.; Zhao, W.; Huang, J.; Li, F.; Sheng, J.; Song, H.; Chen, Y. Development of a dendritic cell/tumor cell fusion cell membrane nano-vaccine for the treatment of ovarian cancer. Front. Immunol., 2022, 13, 828263.
[http://dx.doi.org/10.3389/fimmu.2022.828263] [PMID: 35251013]